Infectious Diseases Clinical Trial
Official title:
Comparative Study of 2% Chlorhexidine Gluconate in 70% Isopropyl Alcohol Against 10% Sodium Hypochlorite as Skin Antiseptics in Human Volunteers
Verified date | September 2011 |
Source | Universidad de Guanajuato |
Contact | n/a |
Is FDA regulated | No |
Health authority | Mexico: Secretaria de Salud |
Study type | Interventional |
The physicians have few options for skin antisepsis. Alternatives for common use antiseptics are costly or ineffective. In order to have more options, this study is needed. The investigators want to know if there are differences between the use of 2% chlorhexidine gluconate in 70% isopropyl alcohol or 10% sodium hypochlorite.
Status | Completed |
Enrollment | 30 |
Est. completion date | January 2012 |
Est. primary completion date | December 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Healthy adult volunteers Exclusion Criteria: - History of skin allergies or atopy, as well as reactions to soaps, chlorine or latex |
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Mexico | University of Guanajuato School of Medicine | Leon | Guanajuato |
Lead Sponsor | Collaborator |
---|---|
Universidad de Guanajuato | Antisepsia Central |
Mexico,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparison of the efficacy of 2% chlorhexidine gluconate in 70% isopropyl alcohol and 10% sodium hypochlorite | Compare decrease in colony forming units in cultures of samples taken with both antiseptics | 24 hours | Yes |
Secondary | Presence of skin reactions for the 2% chlorhexidine gluconate in 70% isopropyl alcohol | Presence of allergy or any reaction at 24 hours after the antiseptic application. | 24 hours | Yes |
Secondary | Presence of allergy or any reaction at 24 hours after the antiseptic application. | Presence of allergy or any reaction at 24 hours after the antiseptic application. | 24 hours | Yes |
Secondary | Bacterial count of skin cultures for the 2% chlorhexidine gluconate in 70% isopropyl alcohol | Bacterial colony count of skin cultures to determine antiseptic properties. After incubation, a blinded technician will count the colonies to determine the colony-forming units per square centimeter (CFU/cm2) of skin. | 24 hours | Yes |
Secondary | Bacterial count of skin cultures for the 10% sodium hypochlorite | Bacterial colony count of skin cultures to determine antiseptic properties. After incubation, a blinded technician will count the colonies to determine the colony-forming units per square centimeter (CFU/cm2) of skin. | 24 hours | Yes |
Secondary | Bacterial count of skin cultures for the control 1 | Scrub with saline solution. Bacterial colony count of skin cultures to determine antiseptic properties. After incubation, a blinded technician will count the colonies to determine the colony-forming units per square centimeter (CFU/cm2) of skin. | 24 hours | Yes |
Secondary | Bacterial count of skin cultures for the control 2 | Sample taken without wash. Bacterial colony count of skin cultures to determine antiseptic properties. After incubation, a blinded technician will count the colonies to determine the colony-forming units per square centimeter (CFU/cm2) of skin. | 24 hours | Yes |
Secondary | Evaluation of antiseptic substantivity | Explore the extended antiseptic activity provide by 2% chlorhexidine gluconate in 70% isopropyl alcohol, 10% sodium hypochlorite and 10% povidone-iodine, by evaluating bacterial grow inhibition in an agar plate. | 24 hours | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02763345 -
The Added Value of a Mobile Application of Community Case Management on Pediatric Referral Rates in Malawi
|
N/A | |
Completed |
NCT00550706 -
Drug Utilization Prevalence in a Pediatric Care Medical Center
|
N/A | |
Completed |
NCT01033799 -
Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers
|
N/A | |
Completed |
NCT00761462 -
BAY 0 9867 Cipro Pediatric Use Study (QUIP)
|
Phase 3 | |
Completed |
NCT05088421 -
A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00828971 -
A Study to Assess Efficacy and Safety of IV/PO Moxifloxacin in the Treatment of cSSSIs
|
Phase 3 | |
Completed |
NCT05468723 -
Evaluating Patient Comfort and Environmental Conditions in the Carecube Negative Pressure Isolation Chamber.1
|
||
Recruiting |
NCT02162966 -
Safety and Efficacy Study of High Dose Colistin
|
Phase 4 | |
Recruiting |
NCT00001281 -
Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
|
||
Active, not recruiting |
NCT02654210 -
LoewenKIDS - Infections and the Development of the Immune System
|
||
Completed |
NCT02226263 -
Severe Necrotizing Enterocolitis in Preterm Newborns <1500g Using Probiotics
|
Phase 2 | |
Terminated |
NCT00211471 -
Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).
|
Phase 2 | |
Active, not recruiting |
NCT04342702 -
A Study on the Prospective Cohort Library of COVID-19 in Southeran
|
||
Completed |
NCT02134548 -
Sensitivity Study of Diagnostic for Detection of Chagas Infection
|
N/A | |
Active, not recruiting |
NCT01611025 -
Hospital Microbial Ecology Follow the Introduction of Ertapenem and Other Newly Introduced Antibiotic Over Time
|
N/A | |
Completed |
NCT01361997 -
Isopropyl Alcohol Against Chlorhexidine - Isopropyl Alcohol as Antiseptics to Prevent Hemoculture's Contamination
|
Phase 3 | |
Completed |
NCT00638677 -
Bifidobacterium Lactis BB12 and Xylitol Delivered With a Novel Slow-release Pacifier
|
Phase 4 | |
Completed |
NCT02434848 -
A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses
|
Phase 2/Phase 3 | |
Completed |
NCT02544139 -
Specificity Study of Diagnostic for Chagas Disease
|
N/A | |
Completed |
NCT00276198 -
Efficacy Trial to Examine Efficacy of Multimicronutrient Home Supplementation in Infants
|
Phase 3 |